Cargando…
Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy
BACKGROUND: Brain metastases (BM) are severe incidents among patients with non-small cell lung cancer (NSCLC) and have been associated with significant morbidity and decreased survival; thus, new methods are required to improve clinical management. Magnetic resonance spectroscopy (MRS) allows noninv...
Autores principales: | Jia, Congli, Li, Zhengquan, Guo, Dong, Zhang, Zhen, Yu, Jingming, Jiang, Guangdong, Xing, Xiaobo, Ji, Shengjun, Jin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764647/ https://www.ncbi.nlm.nih.gov/pubmed/33376357 http://dx.doi.org/10.2147/OTT.S286893 |
Ejemplares similares
-
A Novel Score Combining Magnetic Resonance Spectroscopy Parameters and Systemic Immune-Inflammation Index Improves Prognosis Prediction in Non-Small Cell Lung Cancer Patients With Brain Metastases After Stereotactic Radiotherapy
por: Guo, Dong, et al.
Publicado: (2022) -
Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013) -
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022) -
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022) -
Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)